hemopathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The diagnosis is clear and there are indications for an allogeneic Hematopoietic stem cell. 2. The liver function was normal, and ALT, AST <= 10 ULN and TBIL <= 5 ULN. Bun and CR <= 1.25 ULN. No Cardiac insufficiency was detected by ECG and echocardiography. 3. The patient's legal guardian has the desire and the request to carry on the allogeneic stem cell transplant treatment, and before the treatment signs the informed consent, the informed consent should inform its all clinical research related content, the patient is willing and obeys the treatment plan, follow-up schedules, lab tests.
Exclusion criteria
Exclusion criteria: 1. There are other diseases, such as serious impairment of important organ function: Respiratory Failure, cardiac insufficiency, decompensated hepatic insufficiency, renal insufficiency, etc. 2. Other drugs are being studied by clinical researchers. 3. Who are allergic to PEPTAMEN JUNIOP. 4. Patients with other severe acute or chronic physical or mental disorders, or laboratory abnormalities, may affect patient safety and compliance, informed consent, study participation, follow-up, or interpretation of results.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| GVHD;chimerism;CBC;serum albumin;Prealbumin;Total protein;Liver function;Renal function;Time of granulocyte implantation;Platelet implantation time;Implantation rate;Body weight;Grip strength;Humoral immunity;Cellular immunity;Hospital stay in Laminar flow room; | — |
Secondary
| Measure | Time frame |
|---|---|
| 12-month disease-free survival;6-month disease-free survival;Transplant-related mortality; | — |
Countries
China
Contacts
Children's Hospital of Soochow University